Biolife Solutions (BLFS) Research & Development (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Research & Development data on file, last reported at $2.6 million in Q1 2026.

• Research & Development for Q1 2026 came in at $2.6 million, up 84.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.0 million (up 94.68% YoY), and the FY2025 annual result was $7.6 million, up 59.25% from the prior year.
• Research & Development climbed to $2.6 million in Q1 2026 per BLFS's latest filing, from -$67000.0 in the prior quarter.
• Over five years, Research & Development peaked at $4.2 million in Q1 2023 and troughed at -$5.3 million in Q4 2023.
• A 5-year average of $1.7 million and a median of $2.6 million in 2026 frame the typical range for Research & Development.
• The sharpest annual moves came in 2023 and 2025: Research & Development plunged 167.8% in 2023, then surged 94.62% in 2025.
• A 5-year view of Research & Development shows it stood at -$2.0 million in 2022, then slumped by 167.8% to -$5.3 million in 2023, then surged by 76.3% to -$1.2 million in 2024, then surged by 94.62% to -$67000.0 in 2025, then jumped by 4055.22% to $2.6 million in 2026.
• Business Quant data shows BLFS's Research & Development at $2.6 million in Q1 2026, -$67000.0 in Q4 2025, and $2.7 million in Q3 2025.